Editas Medicine, Inc. (EDIT) › Capital ExpendituresEditas Medicine, Inc. (EDIT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $1.22M2015: $1.43M2016: $3.49M2017: $2.06M2018: $4.75M2019: $6.17M2020: $7.16M2021: $7.98M2022: $4.12M2023: $4.72M2024: $8.83M2025: $607.0K$607.0K2014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$607.0K-93.1%2024$8.83M+87.0%2023$4.72M+14.6%2022$4.12M-48.4%2021$7.98M+11.4%2020$7.16M+16.1%2019$6.17M+29.7%2018$4.75M+130.9%2017$2.06M-41.1%2016$3.49M+144.1%2015$1.43M+17.6%2014$1.22M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share